Canadian healthcare company MDS of Mississauga, Ontario, posted lower sales and a big net loss for its fourth-quarter (end-October 31) financial results.
The company reported total revenue of $322 million. Net revenue was $295 million, a 4% decrease compared to $307 million in the fourth quarter of 2007.
Including a goodwill write-down for its MDS Pharma Services subsidiary and a previously disclosed $246 million after-tax charge to write off its discontinued Maple nuclear reactor project, MDS reported a net loss of $575 million.
The firm's MDS Nordion business reported revenue of $84 million for the quarter, up 9% from $76 million last year.
Related Reading
MDS revenues dip in third quarter, September 4, 2008
MDS plans restructuring, July 18, 2008
MDS sues AECL for $1.6 billion over Maple reactors, July 9, 2008
MDS to press AECL on Chalk River reactors, June 6, 2008
MDS rallies in Q2 results, June 5, 2008
Copyright © 2009 AuntMinnie.com
